New drug cocktail aims to stop bile duct cancer from coming back
Disease control
Not yet recruiting
This study tests whether a combination of two drugs—adebrelimab (given by IV) and S-1 (taken as pills)—can help prevent bile duct cancer from returning after surgery. About 40 adults who had their cancer fully removed will receive the treatment for about 4 months and be monitored…
Phase: PHASE2 • Sponsor: Xingjun Guo • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC